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For	hyperthermia	to	be	used	under	clinical	conditions	for	cancer	therapeutics	the	temperature	regulation	needs	to	be	precise	and	accurately	controllable.	
In	the	case	of	the	metal	nanoparticles	used	for	such	activities,	a	high	coercivity	is	a	prerequisite	in	order	to	couple	more	energy	in	a	single	heating	cycle	for	
efficient	and	faster	differential	heating.	The	chemically	stable	Co-Zn	ferrite	nanoparticles	have	typically	not	been	used	in	such	self-regulating	temperature	
hyperthermia	applications	to	date	due	to	their	low	Curie	temperature	usually	accompanied	with	a	poor	coercivity.	The	latter	physical	property	limitation	
under	clinically	applied	magnetic	field	conditions	(frequency:	100	kHz,	intensity:	200	Oe)	restricts	the	transfer	of	a	reasonable	heat	energy,	and	thus	limits	
the	hyperthermia	efficiency.	Here,	we	report	a	novel	Cr3+	substituted	Co-Zn	ferrite	(Zn0.54Co0.46Cr0.6Fe1.4O4),	whose	Curie	temperature	and	coercivity	values	
are	45.7oC	and	174	Oe,	respectively.	Under	clinically	acceptable	magnetic	field	conditions,	the	temperature	of	these	nanoparticle	suspensions	can	be	self-
regulated	to	44.0oC	and,	most	importantly	with	a	specific	absorption	rate	(SAR)	of	774	W	kg-1,	which	is	two	folds	higher	than	the	SAR	standard	for	magnetic	
nanoparticles	used	in	hyperthermia	(300	W	kg-1).	The	evaluation	of	the	in	vitro	cytotoxicity	of	the	nanoparticles	reports	a	low	toxicity,	which	points	to	a	
novel	set	of	magnetic	nanoparticles	for	use	in	self-regulating	hyperthermia.	
	
Introduction	
Magnetic induction hyperthermia is considered as an accurate, 
efficient and green method for treating malignant tumors. 1 It is part 
of the drive to use nanobiotechnology for the accurate targeting and 
precise delivery of treatments to cancers that circumvents large 
doses of typically toxic drugs that can have major side effects. 2-4 
Basically, magnetic media are introduced to the tumor region by 
implantation or intervention and will generate heat upon the 
application of local external alternating magnetic field. Since 
normal cells possess higher heat resistance and resilience than 
tumor cells, the tumor cells can be killed without affecting normal 
tissue if the temperature can be maintained accurately to within 
42oC-45oC.5-7 
  As monitoring hyperthermia temperature in vivo with minimal 
invasion is still a challenge, magnetic media with low Curie 
temperature, in particular at the hyperthermia temperature range of 
42-45oC, are highly desired. 8-12 The Curie temperature is the 
temperature at which ferromagnetic materials lose their intrinsic 
permanent magnetic properties and consequently lose their ability 
of aligning to external fields and thus facilitating the conversion of 
external electromagnetic energy into highly localized heat. The 
Curie temperature therefore gives an upper limit to the operational 
temperature for the magnetic media. The ability to tune the Curie 
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temperature to a value just above the treatment temperature would 
be an expedient route to control the hyperthermia temperature and 
realize self-regulation in practical use of magnetic media as both 
heater and fuse-limiter. 13 
  To minimize any collateral effects of alternating magnetic fields 
to the human body, the frequency and intensity of the magnetic 
field in clinical treatment should not be higher than 100 kHz and 
200 Oe, respectively. 14 The coercivity (Hc) of the magnetic media 
is considered a key parameter which significantly influences the 
heat transfer efficiency from the alternating magnetic field to the 
human cells. When Hc is higher than the intensity of alternating 
magnetic field, the saturated hysteresis loops cannot be completely 
used to generate heat. As the unsaturated loops are then virtually 
used to generate heat, the heating efficiency is reduced 
precipitously. If Hc is much lower than the intensity of alternating 
magnetic field, although fully saturated hysteresis loops are used, 
the small area of the hysteresis loops will still lead to lower heat 
generation efficiency. 15 Clearly, to achieve a high heating 
efficiency, the Hc of the magnetic media should approach the 
clinically safety intensity threshold (200 Oe) of the alternating 
magnetic field as closely as possible. 
  One of the most widely used magnetic media for hyperthermia 
is Co-Zn ferrite nanoparticles. 16-19 These nanoparticles with spinel 
structure possess high chemical stability which is suitable for 
hyperemia in the complex human body environments. Besides the 
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Curie temperature and Hc, these nanoparticles can be tuned by 
changing the element ratio of Co and Zn, which makes it possible 
to achieve reasonable heat efficiency and hyperthermia 
temperatures. However, the substituting of non-magnetic Zn2+ with 
magnetic Co2+ will cause the reduction of super-exchange 
interaction strength and magnetocrystalline anisotropy in sub-
lattices, resulting in a decrease of the Curie temperature and Hc 
simultaneously. For instance, when the Curie temperature of Co-
Zn ferrite nanoparticles is below 285oC, their Hc is as low as 10 Oe. 
20 This indicates Co-Zn ferrite nanoparticles are not impossible, but 
quite unlikely, to be used in hyperthermia with the self-regulating 
characteristic as the low Curie temperature (45oC) is often 
accompanied by low heating efficiency.  
  In our previous work, we found that substituting Fe3+ by non-
magnetic Cr3+ in the spinel ferrite nanoparticles can decrease the 
Curie temperature and increase Hc simultaneously, which is 
attributed to the effect of Cr3+ on the spinel structure of ferrite in 
the formation process of nanoparticles. 21-23 In addition, the 
analogous valence-bond structure and similar radius of Fe3+ and 
Cr3+ makes their amorphous hydroxide precipitates behave 
thermodynamically to true solid solutions and consequently the 
Cr3+ may be substituted into Co-Zn ferrite without breaking its 
spinel lattice structure and symmetry. 24 Theoretically, substituting 
Cr3+ into Co-Zn ferrite nanoparticles provides the possibility for 
optimizing the Curie temperature and Hc to 45oC and 200 Oe 
simultaneously. In this communication, a certain quantity of Cr3+ 
was substituted into Co-Zn ferrite, ZnxCo1-xCr0.6Fe1.4O4 (x=0, 0.2, 
0.4, 0.54, 0.56) nanoparticles with the Curie temperature ranging 
from 361oC to 35oC and Hc ranging from 6400 Oe to 107 Oe were 
obtained. Among them, the Curie temperature and Hc of 
Zn0.54Co0.46Cr0.6Fe1.4O4 nanoparticles reach 45.7oC and 174 Oe 
respectively. The self-regulating temperature of 
Zn0.54Co0.46Cr0.6Fe1.4O4 nanoparticle suspension is close to the 
hyperthermia temperature (around 44.0oC) and its specific 
absorption rate (SAR) is 774 W kg-1 which is two folds higher than 
the SAR standard for magnetic nanoparticles used in hyperthermia, 
25 under magnetic field with the frequency and intensity at 100 kHz 
and 200 Oe. In addition, the evaluation of in vitro cytotoxicity of 
Zn0.54Co0.46Cr0.6Fe1.4O4 nanoparticles was also performed and no 
obvious toxicity effects were observed in this study. This study 
proposes a methodology for the first time on the bespoke synthesis 
of magnetic nanoparticles for self-regulating hyperthermia. 
 
Experimental	 	
	 	 	
Chemical synthesis 
 
FeCl3·6H2O (99%+) and CrCl3·6H2O (99%+) were obtained from 
Shantou Xilong Chemical Co. Ltd., China. CoCl2·6H2O (99%+) 
and NaOH (96%+) were supplied by Tianjin Bodi Chemical Co. 
Ltd., China. ZnCl2 (98%+) was supplied by Tianjin Damao 
Chemical Co. Ltd., China. CrCl3·6H2O (3.3 mmol), FeCl3·6H2O 
(7.7 mmol) and a quantity of mixture of CoCl2·6H2O and ZnCl2 
(the total amount of the two reagents was 5.5 mmol and the molar 
ratio of the two reagents were 1:0, 0.8:0.2, 0.6:0.4, 0.46:0.54, 
0.44:0.56,) were dissolved in 80 mL deionized water under stirring 
to form a clear solution. Then the NaOH solution (0.5 mol L-1, 150 
mL) was gradually dropped into the previous metal salts solution 
with vigorous stirring for 30 min to form the precursor. The 
precursor was sealed in an autoclave and then heated to 250oC 
(heating rate: 2.3 oC min-1) and maintained for 2 h, and 
subsequently allowed to cool to room temperature. The products 
were washed with deionized water and ethanol until neutral, and 
then dried at 60oC for 6 h in vacuum drying chamber. 
 
Characterization 
 
The crystalline structure was characterized by PANalytical 
Empyrean X-ray diffractometer (Netherlands) with Cu Kα 
radiation (λ=0.15406 nm). The elemental analysis was conducted 
by Shimadzu EPMA-1600 Electron-Probe Microanalyzer (Japan). 
The transmission electron microscope (TEM) images were 
obtained on a FEI Tecnai G2 F30 (USA). Magnetization curves 
were recorded at 25oC on a Jilin University JDM-13 vibrating 
sample magnetometer (China).  
  The Curie temperature was measured by thermogravimetric 
analysis (TGA) using Mettler-Toledo TGA 851 with an Nd-Fe-B 
magnet (100*50*5mm3) placed over the nanoparticles at a distance 
about 10 cm. When the temperature is below the Curie temperature, 
the weights of nanoparticles recorded by TGA are less than the real 
weights due to the attractive magnetic force between nanoparticles 
and the magnet. When the increasing temperature reaches the Curie 
temperature, the nanoparticles will lose their magnetism and the 
weights recorded by TGA are equal to their real weights. The 
weight transition point recorded by TGA is referred to as the Curie 
temperature. 
  The time-dependent temperature curves of nanoparticle 
suspensions were determined by calorimetric measurements. The 
experimental setup is illustrated in Fig. 1v. To make the 
performance of nanoparticles under the alternating magnetic field 
closer to those used for clinical treatment, the experimental 
condition set was as that used in Jordan’s clinical treatment. 26, 27 
All the nanoparticles were decentralized into deionized water with 
the same concentration (112 mg ml-1) and the frequency and 
intensity of the magnetic field set to 100 kHz and 200 Oe, 
respectively. Once irradiated, the temperature of suspension was 
measured by an alcohol thermometer at 60 s intervals.  
 
Cell culture and cytotoxicity assay  
 
Human epidermal keratinocyte (HaCaT) cells were purchased 
from China Center for Type Culture Collection (Wuhan) and 
maintained in high glucose Dulbecco’s Modified Eagle Medium 
(DMEM) (Gibco, USA) in a humidified 37°C incubator (Thermos 
HERAcell150, USA) at 5% CO2 supplemented with 10% fetal 
bovine serum (FBS) (Gibco, USA) and 1% penicillin-streptomycin 
(Gibco, USA). After sterilized with 75% (v/v) ethanol/ deionized 
water for 24 h and rinsed with phosphate buffer saline (PBS) three 
times, the particles were suspended in cell culture medium with a 
concentration of 0 µg ml-1, 12.5 µg ml-1, 25 µg ml-1, 50 µg ml-1, 100 
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µg ml-1 and 200 µg ml-1. HaCat cells were seeded in 24-well plates 
and 96-well plates with a density of 5×104 cells ml-1 for evaluation 
of in vitro cytotoxicity of magnetic nanoparticles. 
  The quantitative evaluation of in vitro cytotoxicity of magnetic 
nanoparticles against HaCat cells were performed by using the cell 
counting kit-8 (CCK-8) assay (Dojindo Laboratories Kumamoto, 
Japan). HaCat cells were seeded in 96-well plates with a density of 
5×104 cells ml-1. After 3 h of culture, adherent cells were exposed 
to the fresh culture medium containing 0 µg ml-1 (control), 12.5 µg 
ml-1, 25 µg ml-1, 50 µg ml-1, 100 µg ml-1 and 200 µg ml-1 
nanoparticles. At 24 h, 48 h and 72 h, the cell viability was assessed. 
Briefly, the culture medium was refreshed and 10 µL CCK-8 was 
added to each well containing 100 µL new medium. After 
incubated in dark at 37 °C for 2 h, each set of nanoparticle solution 
of 100 µL was transferred to a new 96-well plate to measure the 
absorbance of the formazan product at 450 nm by using a 
microplate reader (SPECTRAFLUOR, TECAN, Sunrise, Austria). 
The cell viability was calculated using the formula (1): 
Viability(%)=[ODnanoparticles-ODblank]/[ODcontrol-
ODblank]×100%    (1) 
Where ODnanoparticles is the optical density of the well containing 
various concentration of nanoparticles, DMEM medium and cells. 
ODcontrol is the optical density of the well containing DMEM 
medium and cells. ODblank is the optical density of the well only 
containing DMEM medium. 
  In addition, cell viability was observed by staining with Calcein-
AM, Hoechst 33258, and propidium iodide (PI). After 72 h of 
culture, cells were rinsed with PBS for three times and stained with 
PBS containing 2 µmol L-1 Calcein-AM, 5 µg ml-1 Hoechst 33258, 
and 4 µmol L-1 PI (Sigma, Mo, USA). After incubation in dark at 
37°C for 15 min, cells were rinsed with PBS for three times. Then 
the viable and dead cells were imaged using a fluorescent 
microscope (OLYMPUS BX71, Japan). 
Results	and	Discussion	
The size, morphology and crystalline information of the 
nanoparticle were investigated using TEM. All the nanoparticles 
are of regular tetragonal structure and the edge length of the 
tetragonal structure decreases with increasing Zn content. Fig. 1a, 
1e, 1i, 1m, 1q shows the representative TEM images of 
CoCr0.6Fe1.4O4, Zn0.2Co0.8Cr0.6Fe1.4O4, Zn0.4Co0.6Cr0.6Fe1.4O4, 
Zn0.54Co0.46Cr0.6Fe1.4O4 and Zn0.56Co0.44Cr0.6Fe1.4O4, respectively. 
To obtain the detailed crystalline information of particles, HRTEM 
and electron diffraction were performed. As Fig. 1b, 1f, 1j, 1n, 1r 
indicates, the interlayer distances are 0.489 nm, 0.251 nm, 0.238 
nm, 0.295 nm and 0.256 nm, respectively, corresponding to (111), 
(311), (222), (220) and (311) lattice planes in spinel structure. In 
the electron diffraction images (Fig. 1c, 1g, 1k, 1o, 1s), the dense 
ring patterns match the standard body centered cubic spinel 
structure. 
  The XRD patterns of the nanoparticles are shown in Fig. 1u. All 
the patterns can be easily indexed to cubic spinel structure of 
CoFe2O4-CoCrFe2O4 (JCPDS-ICDD database 03-0864) and no 
obvious XRD peaks arising from impurities could be observed. A 
combination of TEM and XRD analyses confirms the spinel 
structure of the obtained particles. The element ratio in all 
nanoparticles was determined by Electron-Probe Microanalyzer. 
The results, together with the molar ratio of metal elements initially 
added, are given in supplementary materials (Table S-1†). Clearly, 
all metal elements in the nanoparticles do not deviate significantly 
from their initial stoichiometry. According to aforementioned 
experimental facts, it could be concluded that all the metal ions 
successfully enter into the lattice.  
  Fig. 1d, 1h, 1l, 1p, 1t depicts the edge length distributions of 
CoCr0.6Fe1.4O4, Zn0.2Co0.8Cr0.6Fe1.4O4, Zn0.4Co0.6Cr0.6Fe1.4O4, 
Zn0.54Co0.46Cr0.6Fe1.4O4, Zn0.56Co0.44Cr0.6Fe1.4O4 nanoparticles and 
the mean edge length of the nanoparticles are found to be 139.8 nm, 
67.3 nm, 32.2 nm, 30.3 nm and 25.1 nm respectively. Clearly, the 
edge length of the nanoparticles ranges from 20 nm to 200 nm and 
decreases with the increasing Zn content. The plausible 
interpretation is as follows. As the sum of the Zn2+ and Co2+ added 
is fixed, with the increasing quantity of Zn2+, the quantity of 
Zn(OH)2 will also rise and the Co(OH)2 will drop in the precursor. 
Since the saturability of Zn(OH)2 is much lower than the Co(OH)2, 
the overall ions or ionomers content dissolved from the precursor 
into the solution will decrease. This decrease of dissolved ion 
content will inhibit the grain growth due to the deceleration of bulk 
and surface diffusion. 28  
	
  The magnetic properties of these nanoparticles were 
investigated using vibrating sample magnetometer at room 
temperature (25 oC). Fig. 2a shows the detailed magnetization 
curves of the magnetic nanoparticles and its inset depicts the 
changes of Hc and saturation magnetization (Ms) against Zn content. 
As the content of Zn increases, the Ms increases initially and then 
experiences a decrease when the Zn content increases from 0.2 to 
0.56. The magnetization of spinel cubic structure depends on the 
composition of cations in tetrahedral A site and octahedral B site. 
When Zn is added into the lattice, the non-magnetic Zn2+ tends to 
occupy tetrahedral sites by transferring Fe3+ to octahedral sites due 
to their preference by polarization effect, decreasing the magnetic 
moment of sub-lattice A. 29 The Fe3+ transferred from tetrahedral 
site to the octahedral site will lead to the increase of magnetic 
moment of sub-lattice B. The dominant A-B super-exchange 
interactions follow Neel’s two sub-lattice model and the magnetic 
moment of the two sub-lattices are aligned approximately 
antiparallel to each other. 30 The net magnetic moment of the whole 
lattice is given by subtracting the magnetic moments of A sub-
lattice from B sub-lattice. Therefore, the magnetization of the 
nanoparticles will increase with increasing Zn content, which may 
explain the observed initial increase of Ms. 
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Fig. 1	TEM	 images,	 edge	 length	distributions,	XRD	patterns	and	 the	experimental	 setup	of	 calorimetric	measurements	of	 tetragonal	
ZnxCo1-xCr0.6Fe1.4O4	nanoparticles.	CoCr0.6Fe1.4O4:	(a),	(b),	(c),	(d);	Zn0.2Co0.8Cr0.6Fe1.4O4:	(e),	(f),	(g),	(h);	Zn0.4Co0.6Cr0.6Fe1.4O4:	(i),	(j),	(k),	(l);	
Zn0.54Co0.46Cr0.6Fe1.4O4:	(m),	(n),	(o),	(p);	Zn0.56Co0.44Cr0.6Fe1.4O4:	(q),	(r),	(s),	(t).	Among	them,	(a),	(e),	(i),	(m)	and	(q)	are	TEM	images;	(b),	
(f),	(j),	(n)	and	(r)	are	HRTEM	images;	(c),	(g),	(k),	(o)	and	(s)	are	electron	diffraction	images;	(d),	(h),	(l),	(p)	and	(t)	are	the	statistical	data	
of	 size	 distribution	 of	 each	 kind	 of	 nanoparticles	 obtained	 from	 100	 nanoparticles.	 (u)	 XRD	 patterns.	 (v)	 The	 experimental	 setup	 of	
calorimetric	measurements.
  When the content of Zn exceeds 0.2, the magnetic moment of 
the A site are decreased so much so that the dominant A-B super-
exchange interactions become insignificant, with the B-B super-
exchange interactions prevailing, which results in the random spin 
canting on B sites with respect to the direction of spins of the A site. 
31 These canted spins lead to the decrease of the experimental value 
of Ms with the increasing concentration of Zn from 0.2 to 0.56. This 
process could be described by Yafet-Kittle (Y-K) model. 
According to the Y-K model, the existence of canted spins and their 
influence on magnetic moment can be observed by the Y-K angle 
(αY-K) and its value could be calculated using the formula (2) 31   
e
Bn =MB cosαY-K -MA   (2) 
Where
e
Bn ( eBn =MW·MS/5585, MW is the molecular weight) 
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is the experimental magnetic moment expressed in the units of 
Bohr magneton, MA and MB are the Bohr magneton in the A sites 
and B sites. The calculated Y-K angles for each kind of 
nanoparticles are listed in Table 1 and it is clear that the Y-K angle 
gradually increases with the increasing content of Zn. When the 
content of Zn is below 0.2, the Y-K angles are below 38°, and the 
substituting of a small quantity of Zn does not influence the sub-
lattice interactions considerably and the Neel’s two sub-lattice 
model is still valid. When the content of Zn is above 0.2, the Y-K 
angle gradually increases and finally extrapolates to 65.9° when 
the Zn content is 0.56. The substituting of large quantities of Zn 
content significantly influences the sub-lattice interactions and 
Neel’s two sub-lattice model is invalid under this situation. 
  It is also observed that the increase of Zn2+ causes the decrease 
of Hc monotonously, which may result from the change of 
magnetocrystalline anisotropy. The change of magnetocrystalline 
anisotropy could be caused by the following two factors. a) 
Magnetic coupling. The replacement of Co2+ by Zn2+ weakens the 
magnetic coupling in the lattice, which may decrease the 
magnetocrystalline anisotropy and lead to lower Hc. b) Defects. 
There might be some defects in the nanoparticles generated in the 
synthesis process. The presence of defects such as point defects, 
dislocations, stacking faults, subgrain boundaries, inclusions and 
voids might affect the magnetocrystalline anisotropy. 32-34 These 
defects could affect magnetization in two ways. 35 First, they can 
act as centers for nucleation of new domain walls and aid 
magnetization reversal. This can occur at sites which locally have 
large demagnetizing fields due to shape irregularities, or at sites 
where the domain wall energy is locally changed by chemical or 
physical defects. Second, defects can pin existing domain walls and 
inhibit magnetization reversal by creating local energy barriers that 
impede wall movement. In the former case, defects would decrease 
magnetocrystalline anisotropy energy by creating a nucleation site, 
which could decrease Hc; whereas in the latter case, defects would 
increase magnetocrystalline anisotropy energy by pinning domain 
walls, which could increase Hc. It should be pointed out that, it is 
difficult to determine which type of defects and which way of 
affecting magnetization plays the prominent role, but their 
influence on Hc will be exerted by changing magnetocrystalline 
anisotropy. 36 In other words, the changes of magnetocrystalline 
anisotropy in this work might have the contribution of defects, 
although at current stage it is still hard to discern the mechanism. 
  The magnetocrystalline anisotropy constant in our work could 
be calculated by Brown’s relation (3), 37 
Hc=0.96K/Ms    (3) 
The magnetocrystalline anisotropy constant K of each kind of 
nanoparticles were calculated and given in Table 1. The 
magnetocrystalline anisotropy constant of each kind of 
nanoparticles decreases monotonically with the increasing content 
of Zn2+, which accordingly gives rise to the decrease of Hc. 
  The thermogravimetric curves recorded are shown in Fig. 2b. 
As the temperature increases, the nominal weight decreases 
initially and then increases, which means that the magnetization of 
the nanoparticles increases firstly and decreases subsequently with 
the increasing temperature. A plausible interpretation is the 
following. The magnetic field intensity generated from Nd-Fe-B 
magnet is not high enough to make all the magnetic domains in the 
nanoparticles to be oriented in an ordered arrangement. The 
increase of temperature weakens the effect of domain wall pinning, 
38 causing the increase of magnetic susceptibility and consequently 
the increase of magnetization. In addition, the nanoparticles under 
higher temperature have strong tendency to aggregate due to their 
high surface energy, resulting the reduction of surface area. 39, 40 
Since the spin orientation at the surface is more easily disordered 
due to thermal fluctuations than those at the magnetic core, 28 the 
magnetic nanoparticles with lower surface area will have increased 
magnetization. When the temperature reaches the Curie 
temperature, the ordered arrangement of the magnetic domains in 
the nanoparticles will be completely destroyed and the magnetism 
of the nanoparticles will disappear. It is also observed that the 
temperature range of losing magnetization of the nanoparticles is 
broad. This is caused by the individual size differences of 
nanoparticles. According to Nikolaev’s research, 41 the Curie 
temperature is directly proportional to the bulk density of exchange 
bonds. The surface layer thickness increases with the decreasing 
particle radius. Since the number of exchange bonds at the surface 
layer is less than that at the particle core, the smaller the magnetic 
nanoparticle size, the lower the Curie temperature. Thus, the 
temperature range of losing magnetization can also be influenced 
by the size distribution of nanoparticles, as shown in our work. 
When the temperature reaches the Curie temperature of a majority 
of nanoparticles, it will experience the most rapid weight increase 
in the curves and the Curie temperature could be determined by 
taking the maximum value of the first derivative of the 
thermogravimetric curves.  
  With the increasing content of Zn, the Curie temperature 
decreases monotonically, see Fig. 2c (I). The Curie temperature of 
spinel ferrite nanoparticles mainly depends on the following two 
factors. a) The composition of cations in tetrahedral A site and 
octahedral B site, which determines the strength of super-exchange 
interaction of sub-lattices. When Zn is added into the lattice, the 
paramagnetic Zn2+ will cause the reduction of magnetic ions 
concentrations in A sites and reduce the dominant A-B super-
exchange interactions and Curie temperature. 42, 43 b) Particle size. 
When Zn is added, smaller nanoparticles are generated due to the 
decrease of ions or ionomers content dissolved from the precursor 
into the solution. 18 Smaller particle size with a thicker surface 
layer would no doubt lead to lower Curie temperatures. 41 This also 
contributes to the observed decrease of the Curie temperature in 
this work. Compared with the nanoparticles without the 
substituting of Cr (ZnxCo1-xFe2O4) in Arulmurugan’s research (Fig. 
2c ，  II), 22 the Curie temperature of ZnxCo1-xCr0.6Fe1.4O4 
nanoparticles in our work decreases more significantly and in 
particular, the Zn0.54Co0.46Cr0.6Fe1.4O4 nanoparticles with their 
Curie temperature about 45.7oC meets the requirements of self-
regulating hyperthermia.
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Table	1	The	calculated	magnetocrystalline	anisotropy	constant	(K),	Yafet-Kittle	angle	(αY-K)	and	specific	absorption	rate	(SAR)	of	each	kind	
of	nanoparticles	
ZnxCo1-xCr0.6Fe1.4O4 K(erg cm-3)  αY-K (o) SAR(w kg-1) 
x=0 209848.8  22.19  29 
x=0.2 129578.6  37.99  58 
x=0.4 9302.8  53.24  145 
x=0.54 1056.9  63.08  774 
x=0.56 674.7  65.90  464 
                                                                                    
  The time-dependent temperature curves of nanoparticle 
suspensions were determined by calorimetric measurements. All 
the nanoparticles were decentralized into deionized water with the 
same concentration (112 mg/mL) before exposure to the external 
alternating magnetic fields (200 Oe, 100 kHz), which is applicable 
to clinical therapy. As can be seen in Fig. 2d, after being irradiated 
for 60 mins, the temperature of suspension could rise to 28.5oC 
(CoCr0.6Fe1.4O4), 29.4oC (Zn0.2Co0.8Cr0.6Fe1.4O4), 31.6oC 
(Zn0.4Co0.6Cr0.6Fe1.4O4), 33.1oC (Zn0.56Co0.44Cr0.6Fe1.4O4) and 
44.0oC (Zn0.54Co0.46Cr0.6Fe1.4O4). In order to evaluate heat 
efficiency quantitatively, specific absorption rate (SAR) under 
alternating magnetic fields, which describes the energy converted 
into heat per time and mass, was calculated using the formula (4): 
44 
SAR=C(dT/dt)(ms/mm)   (4) 
Where C is the specific heat capacity of suspension and its value is 
4.18 J/gK; dT/dt is the initial slope of the time-dependent 
temperature curve; ms is the mass of suspension and mm is the mass 
of magnetic nanoparticles in the suspension. The calculated results 
are listed in Table 1. The SAR of Zn0.54Co0.46Cr0.6Fe1.4O4 and 
Zn0.56Co0.44Cr0.6Fe1.4O4 nanoparticles are 774 W kg-1 and 464 W 
kg-1 respectively which is at least 3 fold higher than the other three 
kinds of nanoparticles. The heat generation of nanoparticles in this 
work can be attributed to hysteresis loss. The Hc of CoCr0.6Fe1.4O4, 
Zn0.2Co0.8Cr0.6Fe1.4O4 and Zn0.4Co0.6Cr0.6Fe1.4O4 nanoparticles are 
6463 Oe, 3107 Oe and 342 Oe respectively, which are higher than 
the applied alternating magnetic field (200 Oe). This means that 
the saturated hysteresis loops cannot be completely used to 
generate heat. Unsaturated loops could be used，but will generate 
heat only at much reduced levels. 12 The Hc of the 
Zn0.54Co0.6Cr0.6Fe1.4O4 and Zn0.56Co0.6Cr0.6Fe1.4O4 nanoparticles 
are 174 Oe and 107 Oe which are lower than the applied alternating 
magnetic field (200Oe) This means that the hysteresis loops of 
these two kinds of nanoparticles could be completely used to 
generate heat and Zn0.54Co0.6Cr0.6Fe1.4O4 nanoparticles with higher 
Hc and larger hysteresis loops will no doubt possess higher heat 
efficiency.  
  After a rapid increase of temperature, the Zn0.54Co0.6Cr0.6Fe1.4O4 
and Zn0.56Co0.6Cr0.6Fe1.4O4 nanoparticle suspensions reach a stable 
temperature of 33.1oC and 44.0oC, which is close to their Curie 
temperatures, 34.3oC and 45.7oC, respectively. Only when the 
hyperthermia temperature is maintained below the Curie 
temperature, the nanoparticles will keep their magnetism and 
generate sufficient heat under an alternating magnetic field in this 
self-regulating system. Otherwise, the nanoparticles will lose their 
magnetism and will subsequently not generate heat, which makes 
these two suspensions remain constant around the Curie 
temperature of the custom-designed nanoparticles. It is striking to 
notice that the Zn0.54Co0.46Cr0.6Fe1.4O4 nanoparticles with self-
regulated temperature about 44.0oC meets the requirement for 
hyperthermia. 
 
  A further requirement for medical applications involving novel 
nanoparticles is its biocompatibility. The cytotoxicity effects of 
Zn0.54Co0.46Cr0.6Fe1.4O4 nanoparticles with concentrations of 0 µg 
ml-1, 12.5 µg ml-1, 25 µg ml-1, 50 µg ml-1, 100 µg ml-1 and 200 µg 
ml-1 on HaCaT cells was examined after growth in co-culture of 24 
h, 48 h and 72 h. As shown in Fig. 3a, there is no significant 
difference in cell viability between all nanoparticle groups and 
control groups (p-value﹥0.05). In order to have a more visualized 
observation of cell state, live-dead fluorescent microscopic 
analysis was performed. After the co-culture on HaCaT cells with 
Zn0.54Co0.46Cr0.6Fe1.4O4 nanoparticles for 72 h, the cells were next 
stained with Calcein-AM, PI and Hochest 33258. Dead cells can 
then be identified by a red fluorescence generated by the PI after 
intercalating into DNA, which only occurs after the dead cell-
permeable dye molecules enter the cell membrane. Cell nucleus 
can be identified by a blue fluorescence generated by Hochest 
33258 after this living cell-permeable dye molecules bind to DNA. 
Living cells can be identified by a green fluorescence generated by 
the enzymatic hydrolysis of calcein-AM, which only occurs in 
living cells as a result of esterase activity. As can be seen in Fig. 
3b, cells co-cultured with all the concentrations of nanoparticles 
for 72 h show calcein-positive, Hochest 33258-positive and PI-
negative state. The results, together with CCK-8 assay suggest the 
low cytotoxicity of Zn0.54Co0.46Cr0.6Fe1.4O4 nanoparticles.  
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Fig 2. Magnetic	 properties	of	 ZnxCo1-xCr0.6Fe1.4O4	nanoparticles.	 (a)	Magnetization	 curves	 and	 the	 changes	of	Hc	 and	Ms	 against	 the	
content	of	Zn	(Inset).	The	Ms	increases	initially	with	the	content	of	Zn	increasing	from	0	to	0.2,	and	then	experiences	a	decrease	with	the	
content	of	Zn	 increasing	from	0.2	to	0.56,	Hc	decreases	monotonously,	 from	6400	Oe	to	107	Oe.	 (b)	The	thermogravimetric	curves	of	
nanoparticles.	As	the	temperature	increases,	the	nominal	weight	decreases	initially	and	then	increases.	(c)	The	Curie	temperature	against	
the	Zn	content	(I)	and	a	fitted	curve	of	Arulmurugan’s	work	(II),	see	supplementary	materials	(Fig.	S-1†).	With	the	increasing	content	of	
Zn,	Curie	temperature	of	nanoparticles	in	our	work	decreases	monotonically,	from	361.7oC	to	34.3oC.	(d)	Time-dependent	temperature	
curves	of	nanoparticles	in	100	kHz	and	200	Oe	alternating	magnetic	field.	Zn054Co0.46Cr0.6Fe1.4O4	nanoparticles	with	Curie	temperature	at	
45.7oC	and	Hc	at	174	Oe	result	in	the	self-regulating	temperature	of	nanoparticles	suspension	at	hyperthermia	temperature	(around	44.0
oC)	
with	SAR	at	774	W	kg-1
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Fig 3.	Effects	of	Zn0.54Co0.46Cr0.6Fe1.4O4	nanoparticles	on	the	viability	of	Hacat	cells.	(a)	Cell	viability	was	assessed	by	CCK-8	assay	at	24	h,	
48	 h	 and	 72	 h	 after	 co-culture	 with	 various	 concentrations	 of	 Zn0.54Co0.46Cr0.6Fe1.4O4	 nanoparticles.	 Values	 were	 represented	 as	 the	
percentages	 of	 cell	 viability	 compared	 with	 that	 of	 the	 control	 group	 and	 expressed	 as	 means±standard	 deviation	 of	 triplicate	
determinations.	(b)	Representative	fluorescent	images	of	detached	Hacat	cells	which	are	triple	stained	with	calcein-AM	(green),	PI	(red)	
and	Hochest	(blue)	after	co-culture	with	various	concentrations	of	Zn0.54Co0.46Cr0.6Fe1.4O4	nanoparticles	for	72	h.	Scale	bar:	50	μm.	
	
Conclusions	
 
In summary, optimizing the Curie temperature and coercivity of 
Co-Zn ferrite nanoparticles allows for the custom design of self-
regulating hyperthermia nano-vehicles by substituting a pre-
determined quantity of Cr3+ through a hydrothermal process. 
Regular tetragonal morphology nanoparticles with Curie 
temperature from 361.7 oC to 34.3 oC and Hc from 6400 Oe to 107 
Oe were obtained. Among them, the Curie temperature and Hc of 
Zn0.54Co0.46Cr0.6Fe1.4O4 nanoparticles reach 45.7oC and 174 Oe 
respectively. The temperature of these nanoparticles suspension 
can be self-regulated at 44.0oC, close to but critically under the 
clinically used magnetic fields. The evaluation of in vitro 
cytotoxicity of Zn0.54Co0.46Cr0.6Fe1.4O4 nanoparticles also suggests 
low toxicity. This study provides reference information for the 
custom synthesis of a novel magnetic nanoparticle which in the 
future could be used in cancer therapeutics for precise energy 
transfer from the external magnetic field to the tumor via a self-
regulating delivery system to be used in hyperthermia. The data 
shows the bespoke synthesis of nanoparticles to provide the 
necessary physical platform to regulate not just the Curie 
temperature, but also the coercivity by a change in the 
microstructure.	 	
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